New drug among the most potent antibody-drug conjugates in development
During global health crisis, investigational drug proves successful
New findings in prostate and kidney cancer
Neurooncology team uses genetic mapping to target treatment
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Primary results from the phase 3 ANDROMEDA study
Largest retrospective study to date confirms randomized trials
Plasma cell-targeted therapy helps patient with rare condition
Emerging multidisciplinary program seeks better care, outcomes
Largest retrospective series confirms the safety and tolerability
A study of patients with brain metastases treated with SRS
Advertisement
Advertisement